WallStreetZenWallStreetZen

NASDAQ: BDRX
Biodexa Pharmaceuticals PLC Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Biodexa Pharmaceuticals earnings were -$7.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest BDRX earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BDRX reported annual earnings of -$7.2M, with -20.1% growth.

BDRX earnings history

Current Revenue
$0.0
Current Earnings
-$7.2M
Current Profit Margin
0%

BDRX Return on Equity

Current Company
-88.1%
Current Industry
-2%
Current Market
34.1%
BDRX's Return on Equity (-88.1%)... subscribe to Premium to read more.
High Return on Equity Performance

BDRX undefined

Current Company
-45.2%
Current Industry
-0.4%
BDRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BDRX announces earnings.

BDRX undefined

Current Company
-59.66%
Current Industry
5.9%
BDRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BDRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SCNI-$3.46M-$4.70MN/A-$23.60
BDRX-$7.32M-$7.54MN/A-$0.13
SCPX-$19.67M-$28.81MN/A-$102.41
ONCO-$49.74M-$51.60MN/A-$99.33
VINC-$28.98M-$30.07MN/A-$15.85
View Top Biotech Stocks

Biodexa Pharmaceuticals Earnings Reports & History FAQ

What were Biodexa Pharmaceuticals's earnings last quarter?

Biodexa Pharmaceuticals (NASDAQ: BDRX) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total BDRX earnings for the quarter were N/A. In the same quarter last year, Biodexa Pharmaceuticals's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Biodexa Pharmaceuticals stock.

Is Biodexa Pharmaceuticals profitable or losing money?

As of the last Biodexa Pharmaceuticals earnings report, Biodexa Pharmaceuticals is currently losing money. Biodexa Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$7.16 million, a 20.08% decrease year over year.

What was BDRX's earnings growth in the past year?

As of Biodexa Pharmaceuticals's earnings date in Q2 2025, Biodexa Pharmaceuticals's earnings has grown year over year. BDRX earnings in the past year totalled -$7.54 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.